Loss of TMEM65 in mice causes mitochondrial disease mediated by mitochondrial Ca<sup>2</sup>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41980949.
- Also identified by DOI 10.1038/s41467-026-71761-w.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transmembrane protein 65 (TMEM65) depletion in a patient caused severe mitochondrial encephalomyopathy, highlighting its clinical importance. Recent studies show TMEM65 acts as a mitochondrial Na<sup>+</sup>/Ca<sup>2+</sup> exchanger in vitro. Here, we generated conditional Tmem65 knockout mice to define its role in neuromuscular tissues in vivo. Both whole-body and nervous system-specific Tmem65 knockouts exhibited severe growth retardation and seizure-associated sudden death at ~3 weeks, establishing TMEM65 as indispensable for neuronal function. Additionally, skeletal muscle-specific knockout produced adult-onset myopathy preceded by elevated mitochondrial Ca<sup>2+</sup>. Consistently, TMEM65 ablation caused loss of Na<sup>+</sup>-dependent mitochondrial Ca<sup>2+</sup> export. Notably, blocking mitochondrial Ca<sup>2+</sup> entry by mitochondrial calcium uniporter (MCU) knockout rescued the early lethality of whole-body Tmem65 ablation, extending lifespan from ~3 weeks to >1 year. These data reveal an essential physiological role for TMEM65 and suggest that modulating mitochondrial Ca<sup>2+</sup> may offer therapeutic value for TMEM65 misexpression and other mitochondrial diseases associated with Ca<sup>2+</sup> overload.